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of bone explants cultured with estradiol prevented this increase in a dose-
dependent manner (102.5±8.2% at 10nM; 73.4±7.7% at 1000nM; p=0.049)
as well as with pamidronate (79.6±21.8%; p=0.049). The same results were
observed with ARGSV WB with a 41% decrease with estradiol at both doses
and 61% decrease with pamidronate on aggrecanase activity. Direct effect
of estradiol or pamidronate on cartilage explants resulted in a decrease
only with the high dose of estradiol (87.7±24.9%; p=0.049) and with
pamidronate (97.8±8.9%; p=0.049). These results were consistent with data
obtained with ARGSV WB.
Conclusion: These ex vivo results suggest that bone soluble factors are
capable of modulating the remodeling of articular cartilage and indicate the
involvement of catabolic mechanisms. These data provide further evidence
of a cross-talk between bone and cartilage and highlights bone as a
potential target for osteoarthritis therapy.
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Purpose: Pleiotrophin (PTN) is a heparin-binding growth factor expressed
in the cartilage in foetal and young age, but its exact role remains unclear
as yet. The purpose of this paper is to study the expression of PTN and its
receptor protein tyrosine phosphatase beta/zeta (RPTPβ/ζ) in the cartilage
and the subchondral bone of patients with osteoarthritis.
Methods: We studied the cartilage and the subchondral bone from 29 pa-
tients who had undergone total knee and hip arthroplasty for osteoarthritis,
by using Western blot and immunohistochemistry analyses. As controls,
we used eight patients operated for fractures of femoral head, who did not
present radiological or macroscopical osteoarthritic changes
Results: PTN and RPTPβ/ζ were not detected in the cartilage of normal
adults. Their expression and interaction were increased in patients with
osteoarthritis (OA) of moderate radiological and histological severity. PTN
was detected mainly in the cytoplasm, in clusters of superﬁcial chondro-
cytes, in necrotic area chondrocytes and in chondrocytes in the tidemark
zone. Moreover, it was also expressed in subchondral bone osteocytes,
with maximum expression in moderate OA. RPTP β/ζ was also found to be
expressed in the subchondral bone in moderate OA, while, as the severity
of the disease increased, it was found to be expressed in the osteocytes of
the trabecular bone.
Conclusions: The increased expression of PTN and RPTPβ/ζ in the cartilage
and subchondral bone of patients with OA renders these molecules poten-
tially interesting candidate targets for developing a therapeutic approach
to the disease
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Purpose: Osteoarthritis is not only characterized by articular cartilage
destruction but also by an abnormal bone remodeling characterized by
subchondral bone sclerosis and osteophyte formation A growing number
of studies indicate that subchondral bone cells, such as osteoblasts, could
partake in the disease process by releasing mediators involved in articular
cartilage degradation.
Chondroitin sulfate (CS) is a major component of the extracellular matrix
of many connective tissues. This sulfated glycosaminoglycan (GAG), which
is referred as a “symptomatic slow-acting drug in OA” (SySADOA), has been
shown to have anti-inﬂammatory and anti-catabolic properties on chon-
drocytes but little is known about its action on osteoblasts. The objective
of this study was, therefore, to determine the effect of CS on inﬂammatory
mediators and proteolytic enzymes induced by interleukin-1β (IL-1β) and
related to cartilage catabolism in murine osteoblasts.
Methods: Osteoblasts were obtained by enzymatic digestion of calvaria
cortical bone from 5-6-days-old Swiss mice and cultured for 3 weeks as a
primary culture. Cells were then stimulated with 1 or 10 ng/ml of IL-1β
for 24 hours. CS-treated osteoblasts were incubated with 100 μg/ml of CS
during the last week of culture w/o IL-1β. Expressions of cyclooxygenase-2
(COX-2), microsomal prostaglandin E synthase-1 (mPGES-1), 15-hydroxy-
prostaglandin dehydrogenase (15-PGDH), matrix metalloproteinase (MMP)-
3 and -13 were determined by real-time PCR. PGE2 and MMP-3 releases
were analyzed in the medium by enzyme-linked immunosorbent assay.
Results: As expected, IL-1β (at doses of 1 and 10 ng/ml) increased COX-2,
mPGES-1, MMP-3, MMP-13 expression, decreased 15-PGDH expression,
and increased PGE2 and MMP-3 release. Interestingly, CS treatment signiﬁ-
cantly decreased IL-1β-induced expression of COX-2 (by 41% and 65% for
stimulation with 1 ng/ml and 10 ng/ml of IL-1β, respectively), mPGES-1 (by
36% and 55%), MMP-3 (by 25% and 44%) and MMP-13 (by 19% and 49%).
Accordingly, PGE2 and MMP-3 releases were decreased by 57% and 38%
respectively when cells were stimulated with 1 ng/ml of IL-1β, and by 84%
and 50% when cells were stimulated with 10 ng/ml of IL-1β.
Conclusions: Chondroitin sulfate represses the osteoblastic synthesis of
inﬂammatory mediators and proteolytic enzymes involved in cartilage
degradation. These data indicate that the beneﬁcial effects of CS in OA
could not only be due to its action on cartilage but also to its beneﬁcial
effects on subchondral bone.
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Purpose: Osteoarthritis is a degenerative disease characterized by opposing
processes within cartilage and the subchondral bone: cartilage degradation
and osteosclerosis. Osteoclasts themselves are known to have importance
for the coupling between bone resorption and bone formation, as these
cells secrete factors which induce bone formation. However, it is currently
unknown, whether osteoclasts have direct effects on cartilage turnover. The
aim of this study was to further evaluate the effect of osteoclast secreted
factors on both bone formation and cartilage turnover.
Methods: Human monocytes were isolated from blood and differentiated
into mature osteoclasts using M-CSF and RANKL. Conditioned medium (CM)
and corresponding non-conditioned medium (non-CM) were collected dur-
ing culture. The pre-osteoblastic cell line 2T3 and bovine cartilage explants
were subsequently treated with 50% of CM or non-CM in addition to
relevant controls. Bone formation was assessed by Alizarin Red stain-
ing/dye extraction and cartilage formation was measured by PIINP ELISA.
Cartilage degradation was evaluated by ELISA measurements of both MMP
mediated collagen type II (COL II) degradation and aggrecan cleavage, in
addition to histological evaluations of Safranin-O stained explants following
treatments.
Results: Treatment of 2T3 cells with CM from mature osteoclasts (day
7-10 of culture), strongly induced bone formation by 200%, whereas CM
from monocytes and aged osteoclasts had no bone anabolic effect. CM
from mature osteoclasts, with bone anabolic effect, was furthermore tested
in cartilage explant cultures, where it was demonstrated that cartilage
formation was signiﬁcantly decreased by 70%. In addition, degradation of
aggrecans was increased, measured by both ELISA and histological evalua-
tions. In contrast, MMP mediated degradation of COL II was unchanged.
Conclusions: Osteoclasts with a speciﬁc maturity have the ability to
stimulate bone formation by secretion of bone anabolic signals. However,
the same CM had opposite effects on cartilage, namely reduced formation
and accelerated aggrecan degradation. All together, these data point in
the direction of osteoclasts having important roles, for both bone and
cartilage turnover. These observations could be of speciﬁc relevance for
osteoarthritis pathology, in which cartilage catabolic and bone anabolic
processes are taking place at the same time.
